50 likes | 54 Vues
Neurological Immunotherapy: Managing Neurologic Disease in the Era of COVID-19: Focus on Botulinum Toxin is organized by CME Outfitters, LLC and designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)&trade.
E N D
Home / Conferences / Managing Neurologic Disease in the Era of COVID-19: Focus on Botulinum Toxin (Jun 11, 2020 - Jun 11, 2021) Managing Neurologic Disease in the Era of COVID-19: Focus on Botulinum Toxin CME : 0.25 + more Save Start Date : Jun 11, 2020 End Date : Jun 11, 2021 Organized by : CME Out?tters, LLC Specialties : Neurology Fee : Starting From Free Interested Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Overview Credit Info Speaker Contact us Conference Summary Managing Neurologic Disease in the Era of COVID-19: Focus on Botulinum Toxin is organized by CME Out?tters, LLC. Premiere Date: Thursday, June 11, 2020 Credit Expiration Date: Friday, June 11, 2021 This activity offers CE credit for: • Physicians (CME) • Pharmacists (ACPE) • ABIM (MOC) • Other Credit Information: CME Credit (Physicians): CME Out?tters, LLC, designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CPE Credit (Pharmacists): ACPECME Out?tters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0 .25 contact hours (0.025 CEUs) Universal Activity Number: ABIM/MOC Credit: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0 .25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certi?cation (MOC) program. Statement of Need: In response to the spread of COVID-19, it is important to develop a plan for effective and timely patient triage. Especially for patients with spasticity, this initial assessment must factor in quality of life (QoL). It is also critical to provide the appropriate level of care to all patients, irrespective of COVID-19 infection status. Along with assessing QoL, clinicians must ensure medication adherence and stay connected with their patients to address concerns and provide valuable educational tools. This CMEOCast podcast episode focuses on putting the patient at the heart of all care and speci?c interventions for the treatment of spastic paresis during the COVID-19 pandemic. Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Learning Objectives: At the end of this CE activity, participants should be able to: • Optimize care of patients with neurologic disorders during the COVID-19 era. The following learning objectives pertain only to those requesting CNE or CPE credit: • Describe how to optimize care of patients with neurologic disorders during the COVID-19 era. Credit Info CME : 0.25 MOC : 0.25 Contact Hours : 0.25 CEUs : 0.025 Speaker (s) 1 Speaker(s) Contact Us Toll free Number 1(800) 826-2059 Email support@eMedEvents.com Chat Assistant Live Chat Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Add Review Browse CME / CE Conferences by Specialty View All Gastroenterology Haematology Healthcare Management Infectious Disease Medical Education Medicine Neurology Nursing Nutrition Obstetrics and Gynecology Oncology Ophthalmology Orthopedics Pain Management Pediatrics Pharmacy and Medicine Primary Care Psychiatry Psychology Pulmonary Medicine Radiology Rheumatology Surgery Cardiology Clinical Pharmacology Dentistry Dermatology Emergency Medicine Endocrinology Endocrinology, Metabolism and Diabetes For Physicians Logistics Medical Resources Quick Links For Organizers Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Pharma & Medical Devices For Speakers eMedEvents ☰ Follow Us On Download Terms & Conditions | Security | Cookies Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW